Fosun Capital

Fosun Capital company information, Employees & Contact Information

Explore related pages

Related company profiles:

Established in 1992, Shanghai Fosun High Technology (Group) Co., Ltd. ("Fosun") has now grown into the largest privately-owned conglomerate in China. On July 16th 2007, Fosun International (00656.HK), the holding company of Fosun, was listed on the main board of the HKSE. Fosun’s business operations cover 5 segments including pharmaceuticals, property development, steel, mining, retail, services and strategic investments. Fosun Diagonostics is the diagnostics department for Fosunpharma group with 4 affiliated companies.

Company Details

Employees
109
Address
No.830,chengyin Road, Baoshan District, Shanghai,shanghai 200444,china
Industry
Investment Management
NAICS
Other Financial Investment Activities
Portfolio Management
All Other Financial Investment Activities
Trust, Fiduciary, and Custody Activities
Miscellaneous Financial Investment Activities
HQ
Shanghai, Shanghai
Looking for a particular Fosun Capital employee's phone or email?

Fosun Capital Questions

News

Teva and Fosun Pharma Enter into a Strategic Partnership to Develop Novel Anti-PD1-IL2 Therapy (TEV-56278) in Immuno-Oncology - Yahoo Finance

Teva and Fosun Pharma Enter into a Strategic Partnership to Develop Novel Anti-PD1-IL2 Therapy (TEV-56278) in Immuno-Oncology Yahoo Finance

Fosun Pharma Deeply Embraces AI, Self-developed PharmAID Decision Intelligence Platform Boosts Efficient Innovation - PR Newswire

Fosun Pharma Deeply Embraces AI, Self-developed PharmAID Decision Intelligence Platform Boosts Efficient Innovation PR Newswire

China’s NMPA Accepts MAA for Foritinib in ALK+ Advanced NSCLC - OncLive

China’s NMPA Accepts MAA for Foritinib in ALK+ Advanced NSCLC OncLive

Insilico delivers second preclinical candidate compound (PCC) to Fosun Pharma - EurekAlert!

Insilico delivers second preclinical candidate compound (PCC) to Fosun Pharma EurekAlert!

Neovii and Fosun Pharma Enter Into an Exclusive Agreement - Newswire.com

Neovii and Fosun Pharma Enter Into an Exclusive Agreement Newswire.com

China: FOSUN COVID-19 Response Project - Asian Infrastructure Investment Bank (AIIB)

China: FOSUN COVID-19 Response Project Asian Infrastructure Investment Bank (AIIB)

Cellusion and Celregen, a member of Fosun Pharma, Enter into Exclusive License Agreement of CLS001 for a Corneal Endothelial Cell Regenerative Therapy in the Greater China Region - Business Wire

Cellusion and Celregen, a member of Fosun Pharma, Enter into Exclusive License Agreement of CLS001 for a Corneal Endothelial Cell Regenerative Therapy in the Greater China Region Business Wire

Fosun Pharma and Insilico Medicine Announce a Strategic, AI-driven Drug Discovery and Development Collaboration to Jointly Advance Multiple Targets - PR Newswire

Fosun Pharma and Insilico Medicine Announce a Strategic, AI-driven Drug Discovery and Development Collaboration to Jointly Advance Multiple Targets PR Newswire

Safety and immunogenicity of the SARS-CoV-2 BNT162b1 mRNA vaccine in younger and older Chinese adults: a randomized, placebo-controlled, double-blind phase 1 study - Nature

Safety and immunogenicity of the SARS-CoV-2 BNT162b1 mRNA vaccine in younger and older Chinese adults: a randomized, placebo-controlled, double-blind phase 1 study Nature

Population pharmacokinetics of FCN-159, a MEK1/2 inhibitor, in adult patients with advanced melanoma and neurofibromatosis type 1 (NF1) and model informed dosing recommendations for NF1 pediatrics - Frontiers

Population pharmacokinetics of FCN-159, a MEK1/2 inhibitor, in adult patients with advanced melanoma and neurofibromatosis type 1 (NF1) and model informed dosing recommendations for NF1 pediatrics Frontiers

Revance Announces China Market License Agreement with Fosun Pharma for RT002 - NAI500

Revance Announces China Market License Agreement with Fosun Pharma for RT002 NAI500

Immunogenicity and safety of BNT162b2 mRNA vaccine in Chinese adults: A phase 2 randomised clinical trial - The Lancet

Immunogenicity and safety of BNT162b2 mRNA vaccine in Chinese adults: A phase 2 randomised clinical trial The Lancet

Fosun Pharma Participates in BEYOND Expo 2023 to Showcase Its Innovative R&D Achievements - PR Newswire

Fosun Pharma Participates in BEYOND Expo 2023 to Showcase Its Innovative R&D Achievements PR Newswire

New Frontier Corporation to Acquire United Family Healthcare - GlobeNewswire

New Frontier Corporation to Acquire United Family Healthcare GlobeNewswire

Fosun Pharma Participates in 2023 BIO International Convention to Demonstrate its Global Innovation Capabilities - PR Newswire

Fosun Pharma Participates in 2023 BIO International Convention to Demonstrate its Global Innovation Capabilities PR Newswire

Fosun Pharma Announces 2020 Annual Results - PR Newswire

Fosun Pharma Announces 2020 Annual Results PR Newswire

MimiVax LLC and Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. announce exclusive licensing agreement on SurVaxM for glioblastoma treatment in China - PR Newswire

MimiVax LLC and Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. announce exclusive licensing agreement on SurVaxM for glioblastoma treatment in China PR Newswire

Top Fosun Capital Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant